Antibacterial Susceptibility of Clinical Isolates of Klebsiella pneumoniae in Nigeria to Carbapenems

Authors

  • Elijah Kolawole Oladipo Department of Microbiology, Laboratory of Molecular Biology, Bioinformatics and Immunology, Adeleke University, P.M.B 250, Ede, Osun State, Nigeria.
  • Elukunbi Hilda Awoyelu Department of Pure and Applied Biology (Microbiology/Virology Unit), Ladoke Akintola University, P.M.B 4000, Ogbomoso, Nigeria
  • Idowu Jesulayomi Adeosun Department of Microbiology, Laboratory of Molecular Biology, Bioinformatics and Immunology, Adeleke University, P.M.B 250, Ede, Osun State, Nigeria
  • Abiodun A Ayandele Department of Pure and Applied Biology (Microbiology/Virology Unit), Ladoke Akintola University, P.M.B 4000, Ogbomoso, Nigeria

DOI:

https://doi.org/10.24996/ijs.2021.62.2.5

Keywords:

Antibiotic resistance, Aminoglycosides, Carbapenems, Clinical isolates, Klebsiella pneumoniae

Abstract

The emergent bacterial resistance to antibiotics, most especially Carbapenems, has become a common phenomenon. The aim of the recent study was the observation and evaluation of the antibacterial susceptibility of Klebsiella pneumoniae in clinical specimens to different Carbapenems. One hundred isolates of K. pneumoniae isolated from different clinical sites, such as leg, caesarean section (CS), head, buttock, breast, thigh, and arm were tested. Using disc diffusion method, the isolates were tested for susceptibility to different antibiotics including Tobramycin, Ciprofloxacin, Aztreonam, Colistin sulphate, Ceftriaxone, Cefepime, Cefoxitin, Ceftazidime, Ertapenem, Meropenem, and Imipenem. The results were interpreted according to the Clinical and Laboratory Standard Institute disk diffusion standard. All K. pneumoniae isolates were highly susceptible to all classes of Carbapenems: Imipenem (99%), Meropenem (96%) and Ertapenem (91%). However, they were highly resistant to Ciprofloxacin (97%), Ceftriaxone (91%) and Tobramycin (73%).  Despite the recent emergence of multi-drug resistant bacteria to Carbapenems, this study showed that Carbapenems could still be used in treating different infections caused by multi-drug resistant K. pneumoniae.

Downloads

Download data is not yet available.

Downloads

Published

2021-02-26

Issue

Section

Biology

How to Cite

Antibacterial Susceptibility of Clinical Isolates of Klebsiella pneumoniae in Nigeria to Carbapenems . (2021). Iraqi Journal of Science, 62(2), 396-401. https://doi.org/10.24996/ijs.2021.62.2.5

Similar Articles

1-10 of 423

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)